To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease
A Clinical Study of the TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Diseases for Non-Surgical Candidates Under the Physician Sponsored IDE.
2 other identifiers
interventional
100
1 country
1
Brief Summary
PURPOSE OF RESEARCH: Endovascular stent-graft repair of aortic pathologies is a minimally-invasive alternative to open surgery that may decrease morbidity and mortality, particularly in high risk patients. Optimal patient selection, based on pathology and anatomy, is being defined. Technically successful implantation requires adequate assessment of pathology and anatomy, and development and execution of novel and delicate procedures that resolve the pathology while minimizing morbidity and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Oct 2001
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2001
CompletedFirst Submitted
Initial submission to the registry
September 18, 2008
CompletedFirst Posted
Study publicly available on registry
September 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedResults Posted
Study results publicly available
March 1, 2017
CompletedMarch 1, 2017
January 1, 2017
11.8 years
September 18, 2008
January 10, 2017
January 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Participants With Technically Successful Implant
The percentage of participants with technically successful implantation as assessed by the investigator is reported.
Day 0 to Day 30
Secondary Outcomes (2)
Count of Participants Experiencing at Least One Endoleak Following Procedure
Up to 60 months following procedure
Overall Survival
60 months
Study Arms (1)
Treatment Arm - Placement of TAG device
EXPERIMENTALA TAG device will be used to repair the pathology in the thoracic aorta
Interventions
A TAG device will be used to repair the pathology in the thoracic aorta
Eligibility Criteria
You may qualify if:
- Patients should be poor or high risk open surgical candidates.
- Anatomy meets TAG Endoprosthesis specification criteria.
- Minimum 2 cm non-aneurysmal segment proximal and distal to the aneurysm
- \<60 angle in the aortic arch may require additional length of non-aneurysmal segment is the arch is included in the treatment segment.
- Ability to comply with protocol requirements including follow-up.
- Signed Informed Consent
You may not qualify if:
- \>4mm aortic taper and inability to use devices of different diameters, to compensate for the taper, in the treatment area of the aorta.
- Significant thrombus at the proximal or distal implantation sites.
- Planned occlusion of the left carotid or celiac arteries, unless supplemental conduit or alternate perfusion routes for end organ(s) provided.
- Degenerative connective tissue disease, e.g. Marfan's or Ehler's Danlos Syndrome, unless the proximal and distal implantation sites of the TAG Endoprosthesis are located with in previous surgical grafts.
- \. Female of child bearing age with positive pregnancy test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Daniel Sze, Principal Investigator
- Organization
- Stanford University
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Yung-Ho Sze
Stanford University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
September 18, 2008
First Posted
September 22, 2008
Study Start
October 1, 2001
Primary Completion
July 1, 2013
Study Completion
May 1, 2014
Last Updated
March 1, 2017
Results First Posted
March 1, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will share
Data is made available upon request to colleagues conducting similar studies throughout the US.